- Recommendations on Minimal Residual Disease Monitoring in Acute Promyelocytic Leukemia Treated with Combination of All- Trans Retinoic Acid and Arsenic TrioxideChen, Li; Zhu, Hongming; Dong, Fangyi; Li, Yan; Liu, Qifa; Hu, Yu; Zhang, Yicheng; Jin, Jie; Hu, Jianda; Liu, Ting; Wu, Depei; Chen, Jieping; Lai, Yongrong; Wang, Jianxiang; Li, Juan; Li, Jianyong; Du, Xin; Wang, Xin; Yang, Mingzhen; Yan, Jinsong; Ouyang, Guifang; Liu, Li; Hou, Ming; Huang, Xiaojun; Jin, Wen; Zhu, Yongmei; Li, Jian; Wang, Kankan; Chen, Zhu; Chen, Sai-Juan; Li, Junmin65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Association of Genetic Characteristics with Response to Venetoclax Plus Hypomethylating Agents in Relapsed and Refractory Acute Myeloid LeukemiaWeng, Guangyang; Zhang, Yu; Yu, Guopan; Xu, Na; Sun, Zhiqiang; Lin, Dongjun; Liang, Xinquan; Deng, Lan; Xiao, Jie; Zhang, Hongyu; Guo, Ziwen; Jin, Hua; Du, Xin; Liu, Qifa64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.被引 2
- Dynamics of Minimal Residual Disease Defines a Novel Risk-Classification and the Role of Allo-HSCT in Adult Ph-Negative B Cell Acute Lymphoblastic LeukemiaZihong, Cai; Tang, Bingqing; Xu, Xiuli; Huang, Zicong; Liu, Qifa; Zhou, Hongsheng64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
会议论文
Dynamic Assessment of Measurable Residual Disease in Favorable-Risk Acute Myeloid Leukemia in First Remission, Treatment, and Outcomes
4阅读
